Cover Image

A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against <i>S. pneumoniae</i> in Mice

Combining amoxicillin with the immunostimulatory toll-like receptor 4 agonist monophosphoryl lipid A (MPLA) represents an innovative approach for enhancing antibacterial treatment success. Exploiting pharmacokinetic and pharmacodynamic data from an infection model of <i>Streptococcus pneumonia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sebastian Franck (Author), Robin Michelet (Author), Fiordiligie Casilag (Author), Jean-Claude Sirard (Author), Sebastian G. Wicha (Author), Charlotte Kloft (Author)
Format:	Book
Published:	MDPI AG, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia
by: Robin Michelet, et al.
Published: (2021)

Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure-Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant <i>Escherichia coli</i>
by: Johanna Seeger, et al.
Published: (2021)

Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer
by: Debra Wu, et al.
Published: (2021)

Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Jiayuan Zhang, et al.
Published: (2023)

Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism
by: Josefine Schulz, et al.
Published: (2022)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Carbapenem-Resistant <i>Escherichia coli</i>
by: Kamonchanok Jitaree, et al.
Published: (2019)

Prediction of the Drug-Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model
by: Zhuodu Wei, et al.
Published: (2023)

Editorial: <i>Antibiotics</i> Special Issue on Pharmacokinetic/Pharmacodynamic Models of Antibiotics
by: Razieh Kebriaei, et al.
Published: (2022)

Determination of Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Parameters of Doxycycline against <i>Edwardsiella ictaluri</i> in Yellow Catfish (<i>Pelteobagrus fulvidraco</i>)
by: Ning Xu, et al.
Published: (2021)

Vitamin E Phosphate Nucleoside Prodrugs: A Platform for Intracellular Delivery of Monophosphorylated Nucleosides
by: Richard Daifuku, et al.
Published: (2018)

Pharmacokinetics and Pharmacodynamics of Salvinorin A and <i>Salvia divinorum</i>: Clinical and Forensic Aspects
by: Andreia Machado Brito-, et al.
Published: (2021)

Pharmacokinetic-Pharmacodynamic Correlation Analysis of <i>Rhodiola crenulata</i> in Rats with Myocardial Ischemia
by: Zhixin Jia, et al.
Published: (2024)

Influence of Intramuscular Injection Sites on Pharmacokinetics of Amoxicillin in Olive Flounder (<i>Paralichthys olivaceus</i>) and Its Implication for Antibacterial Efficacy
by: Ji-Hoon Lee, et al.
Published: (2023)

Amoxicillin and Clarithromycin Mucoadhesive Delivery System for <i>Helicobacter pylori</i> Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy
by: Isabel Villegas, et al.
Published: (2021)

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
by: Jan-Willem C. Alffenaar, et al.
Published: (2022)

Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
by: Barbara L Mui, et al.
Published: (2013)

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
by: Thi-, et al.
Published: (2022)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing <i>Enterobacter cloacae</i> and <i>Klebsiella pneumoniae</i> in Murine Pneumonia Model
by: Mao Hagihara, et al.
Published: (2021)

Changes in Pharmacokinetics and Pharmacodynamics of Losartan in Experimental Diseased Rats Treated with <i>Curcuma longa</i> and <i>Lepidium sativum</i>
by: Abdul Ahad, et al.
Published: (2022)

Concentration-Dependent Activity of Pazufloxacin against <i>Pseudomonas aeruginosa</i>: An In Vivo Pharmacokinetic/Pharmacodynamic Study
by: Yasuhiro Umezaki, et al.
Published: (2022)

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Katharina Rox, et al.
Published: (2022)

A population pharmacokinetic and pharmacokinetic‐pharmacodynamic analysis of vupanorsen from phase I and phase II studies
by: Jae Eun Ahn, et al.
Published: (2023)

Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a
by: Qing Liu, et al.
Published: (2020)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
by: Lee SY, et al.
Published: (2015)

In Vivo Pharmacodynamics of <i>Calophyllum soulattri</i> as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
by: Inarah Fajriaty, et al.
Published: (2023)

QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles
by: Erwin G. Abucayon, et al.
Published: (2023)

Population Pharmacokinetic/Pharmacodynamic Study of Linezolid in Hospital-Acquired Pneumonia Patients with Renal Insufficiency
by: Xu J, et al.
Published: (2024)

AMOXICILLIN/CLAVULANAT EFFICIENCY FOR TREATMENT OF CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA
by: O.I. Pikuza, et al.
Published: (2006)

AMOXICILLIN/CLAVULANAT EFFICIENCY FOR TREATMENT OF CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA
by: O.I. Pikuza, et al.
Published: (2006)

Novel Mutations Conferring Amoxicillin Resistance in <i>Helicobacter pylori</i> in South Korea
by: Soon Young Park, et al.
Published: (2023)

Optimizing Antibiotic Therapy for <i>Stenotrophomonas maltophilia</i> Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach
by: Helena Barrasa, et al.
Published: (2024)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
by: Zhenwei Yu, et al.
Published: (2022)

Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
by: Xin Li, et al.
Published: (2021)

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection
by: Laura Sibley, et al.
Published: (2022)

Preparation of Aditoprim Injection against <i>Streptococcus suis</i> in Pigs and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling
by: Wei Qu, et al.
Published: (2022)

Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
by: Undine Falkenhagen, et al.
Published: (2023)